Overview

Efficacy and Tolerability Study of Avanafil in Russia

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Primary Objective: o To assess the change in percent of sexual attempts in which subjects are able to maintain an erection of sufficient duration to have successful intercourse between the run-in period and treatment period: - The change in percent of sexual attempts in which subjects are able to insert the penis into the partner's vagina. - The change in score on the erectile function (EF) domain of the International Index of Erectile Function (IIEF) questionnaire. Secondary Objective: o To evaluate the safety and tolerability of avanafil in patients with erectile dysfunction (ED).
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi